Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
drug approval
Pharma
Mirum scores FDA approval for ultra-rare disorder
Rare disease pharma Mirum scored an approval for its ultra-rare bone lesion treatment it bought from Incyte.
Donavyn Coffey
Sep 25, 2026 4:10pm
In landmark for Korean biotech, Elevar wins FDA nod for Lyrfigtu
Sep 24, 2026 11:25am
Bayer’s Kerendia scores FDA nod for CKD in Type 1 diabetes
Sep 17, 2026 2:06pm
Takeda wins FDA nod for first-in-class blood cancer drug Mimrylo
Aug 28, 2026 10:04pm
Gilead crosses FDA finish line with new HIV combo pill
Aug 27, 2026 5:56pm
BMS bags first FDA approval for CELMoD franchise with Zenbexus
Aug 14, 2026 10:09am